The two cough medicines, Ambronol and Dok 1 Max are made by Marion Biotech Limited, a Noida-based company. After the company’s product was connected to deaths in Uzbekistan, the World Health Organization on Wednesday advised against using two cough syrups made by an Indian pharmaceutical company. Cough Syrups-Cough Syrups-Cough Syrups
The Dok 1 Max syrup was made by Mario Biotech Limited in Noida, according to information released by the Uzbekistan health ministry on December 27. The Indian government announced two days later that samples of the medication had been sent for testing.What happened in Uzbekistan
The Dok-1 Max cough syrup, produced by Noida-based Mario Biotech, was found to have caused the deaths of 18 out of 21 children with acute respiratory infections, according to the press service of the Uzbekistan health ministry. The ministry added that ethylene glycol was discovered in Dok-1 Max during scientific tests.
Speaking at a routine media briefing, a spokesperson for the external affairs ministry, Arindam Bagchi, called the deaths of the 18 youngsters in Uzbekistan “unfortunate.” He continued the Uzbekistan government hasn’t formally raised the issue with us. However, the Uzbekistan embassy has spoken to the Uzbek side and requested further information about their investigation.WHO Caution to UzbekistanDue to their “substandard” quality, the international health organization on Wednesday advised against using Dok 1 Max and Ambronol, both made by the Noida-based company. Ambronol and Dok 1 Max “had inappropriate quantities of diethylene glycol and ethylene glycol as impurities,” according to a laboratory examination conducted by Uzbekistan authorities, the WHO medical product notice.Ethylene glycol is present in industrial-grade glycerine that is not allowed for therapeutic use, is included in syrups, and is ideally not supposed to be in even trace amounts. Diethylene glycol and ethylene glycol have been linked to abrupt renal failure, convulsions, vomiting, and circulatory system damage.The dangerous goods included in this advisory, mainly when used on youngsters, “may cause serious harm or death,” according to the WHO. Abdominal discomfort, nausea, vomiting, diarrhea, difficulty passing urine, headache, changed mental status, and severe renal injury, which may result in death, are just a few toxic consequences.The WHO had already issued a global alert for drugs made in India in October. Four kinds of cough syrup made by maiden pharmaceuticals, a Haryana-based company, were the subject of the notice. The WHO has stated that a laboratory examination of the syrups confirms that they contain prohibited levels of diethylene glycol and ethylene glycol as pollutants. To protect patients from damage, World Health Organization also stated that it was critical to identify and remove the two syrups from circulation. Cough Syrups-Cough Syrups-Cough Syrups
Mario Biotech Production License has been Revoked.According to a drug officer in Uttar Pradesh who spoke on Thursday, Mario Biotech’s production license was suspended on January 10. According to Gautam Buddh Nagar district drug inspector Vaibhav Babbar, during an examination by federal agencies and the Uttar Pradesh drug department on December 29, company officials could not show papers about the manufacture of Dok 1 Max cough syrup, the same syrup that has been supplied to Uzbekistan. Following that, the decision to suspend the company’s license was made.Mario Biotech said on December 29 that it had ceased production of the Dok 1 Max cough medicine. Hasan Harris, the head of the legal department, insisted that the company’s testing of the cough syrup went without incident.ConclusionHowever, on December 13, India’s Drugs Controller General, VG Somani, asserted that the syrup samples were examined in a government laboratory and confirmed to comply with the rules. Test results also indicated no ethylene or diethylene glycol contamination in the syrups.Visit our website for more news articles where we share The True Stories of The Word, TopStoriesWorld.com.
Cough Syrups-Cough Syrups-Cough Syrups
The Dok 1 Max syrup was made by Mario Biotech Limited in Noida, according to information released by the Uzbekistan health ministry on December 27. The Indian government announced two days later that samples of the medication had been sent for testing.
What happened in Uzbekistan
The Dok-1 Max cough syrup, produced by Noida-based Mario Biotech, was found to have caused the deaths of 18 out of 21 children with acute respiratory infections, according to the press service of the Uzbekistan health ministry. The ministry added that ethylene glycol was discovered in Dok-1 Max during scientific tests.
Speaking at a routine media briefing, a spokesperson for the external affairs ministry, Arindam Bagchi, called the deaths of the 18 youngsters in Uzbekistan “unfortunate.” He continued the Uzbekistan government hasn’t formally raised the issue with us. However, the Uzbekistan embassy has spoken to the Uzbek side and requested further information about their investigation.
WHO Caution to Uzbekistan
Due to their “substandard” quality, the international health organization on Wednesday advised against using Dok 1 Max and Ambronol, both made by the Noida-based company. Ambronol and Dok 1 Max “had inappropriate quantities of diethylene glycol and ethylene glycol as impurities,” according to a laboratory examination conducted by Uzbekistan authorities, the WHO medical product notice.
Ethylene glycol is present in industrial-grade glycerine that is not allowed for therapeutic use, is included in syrups, and is ideally not supposed to be in even trace amounts. Diethylene glycol and ethylene glycol have been linked to abrupt renal failure, convulsions, vomiting, and circulatory system damage.
The dangerous goods included in this advisory, mainly when used on youngsters, “may cause serious harm or death,” according to the WHO. Abdominal discomfort, nausea, vomiting, diarrhea, difficulty passing urine, headache, changed mental status, and severe renal injury, which may result in death, are just a few toxic consequences.
The WHO had already issued a global alert for drugs made in India in October. Four kinds of cough syrup made by maiden pharmaceuticals, a Haryana-based company, were the subject of the notice.
The WHO has stated that a laboratory examination of the syrups confirms that they contain prohibited levels of diethylene glycol and ethylene glycol as pollutants. To protect patients from damage, World Health Organization also stated that it was critical to identify and remove the two syrups from circulation.
Cough Syrups-Cough Syrups-Cough Syrups
Mario Biotech Production License has been Revoked.
According to a drug officer in Uttar Pradesh who spoke on Thursday, Mario Biotech’s production license was suspended on January 10. According to Gautam Buddh Nagar district drug inspector Vaibhav Babbar, during an examination by federal agencies and the Uttar Pradesh drug department on December 29, company officials could not show papers about the manufacture of Dok 1 Max cough syrup, the same syrup that has been supplied to Uzbekistan. Following that, the decision to suspend the company’s license was made.
Mario Biotech said on December 29 that it had ceased production of the Dok 1 Max cough medicine. Hasan Harris, the head of the legal department, insisted that the company’s testing of the cough syrup went without incident.
Conclusion
However, on December 13, India’s Drugs Controller General, VG Somani, asserted that the syrup samples were examined in a government laboratory and confirmed to comply with the rules. Test results also indicated no ethylene or diethylene glycol contamination in the syrups.
Visit our website for more news articles where we share The True Stories of The Word, TopStoriesWorld.com.
